Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-06-05 @ 8:40 AM
Study NCT ID:
NCT01593527
Status:
WITHDRAWN
Last Update Posted:
2017-04-20
First Post:
2012-05-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CACZ885H2402
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None